SURPASS-CVOT: Tirzepatide Significantly Reduces Major Kidney Events Compared to Dulaglutide in T2D – Docwire News
SURPASS-CVOT: Tirzepatide Significantly Reduces Major Kidney Events Compared to Dulaglutide in T2D Docwire News
المصدر: Google News — Pakistan / HEALTH
0
مشاهدة



